Quinapril Treatment Increases Insulin-Stimulated Endothelial Function and Adiponectin Gene Expression in Patients with Type 2 Diabetes

Objective: Angiotensin-converting enzyme inhibitors reduce cardiovascular mortality and improve endothelial function in type 2 diabetic patients. We hypothesized that 2 months of quinapril treatment would improve insulin-stimulated endothelial function and glucose uptake in type 2 diabetic subjects...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of clinical endocrinology and metabolism 2006-03, Vol.91 (3), p.1001-1008
Hauptverfasser:	Hermann, Thomas S., Li, Weijie, Dominguez, Helena, Ihlemann, Nikolaj, Rask-Madsen, Christian, Major-Pedersen, Atheline, Nielsen, Dorthe Baunbjerg, Hansen, Kaj Winther, Hawkins, Meredith, Kober, Lars, Torp-Pedersen, Christian
Format:	Artikel
Sprache:	eng
Schlagworte:	Adiponectin - genetics Angiotensin-Converting Enzyme Inhibitors - therapeutic use Base Sequence Biological and medical sciences Blood Pressure - drug effects Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - genetics Diabetes. Impaired glucose tolerance Diabetic Angiopathies - prevention & control DNA Primers Endocrine pancreas. Apud cells (diseases) Endocrinopathies Endothelium, Vascular - drug effects Endothelium, Vascular - physiopathology Etiopathogenesis. Screening. Investigations. Target tissue resistance Female Fundamental and applied biological sciences. Psychology Gene Expression Regulation Heart Rate - drug effects Humans Hypoglycemic Agents - therapeutic use Insulin - pharmacology Male Medical sciences Middle Aged Polymerase Chain Reaction Tetrahydroisoquinolines - therapeutic use Vertebrates: endocrinology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!